Table 3.
OP metabolite | Population | N | LOQ | %>LOQ | Min | 25% | 50% | 75% | Max |
---|---|---|---|---|---|---|---|---|---|
DEP (ng/mL) | Case | 259 | 1.089 | 67.3 | <LOQ | <LOQ | 1.67 | 3.27 | 32.8 |
Sub-cohort | 548 | 1.089 | 67.4 | <LOQ | <LOQ | 1.68 | 3.49 | 25.9 | |
DETP (ng/mL) | Case | 259 | 0.594 | 41.5 | <LOQ | <LOQ | <LOQ | 1.37 | 25.0 |
Sub-cohort | 548 | 0.594 | 47.4 | <LOQ | <LOQ | <LOQ | 1.58 | 131 | |
DEDTP (ng/mL) | Case | 259 | 0.594 | 0.38 | <LOQ | <LOQ | <LOQ | <LOQ | <LOQ |
Sub-cohort | 548 | 0.594 | 0.18 | <LOQ | <LOQ | <LOQ | <LOQ | <LOQ | |
Sum DEP * (nmol/L) | Case | 259 | NA | NA | 2.04 | 10.1 | 18.2 | 34.3 | 241 |
Sub-cohort | 547 | NA | NA | 0.02 | 11.5 | 19.7 | 37.3 | 581 | |
DMP (ng/mL) | Case | 259 | 3.003 | 47.7 | <LOQ | <LOQ | <LOQ | 7.01 | 91.8 |
Sub-cohort | 547 | 3.003 | 52.3 | <LOQ | <LOQ | 3.27 | 10.2 | 168 | |
DMTP (ng/mL) | Case | 259 | 0.429 | 89.6 | <LOQ | 0.91 | 2.09 | 5.18 | 68.6 |
Sub-cohort | 548 | 0.429 | 93.3 | <LOQ | 1.05 | 2.58 | 8.06 | 221 | |
DMDTP (ng/mL) | Case | 259 | 1.320 | 13.5 | <LOQ | <LOQ | <LOQ | <LOQ | 37.6 |
Sub-cohort | 548 | 1.320 | 16.9 | <LOQ | <LOQ | <LOQ | <LOQ | 83.9 | |
Sum DMP * (nmol/L) | Case | 259 | NA | NA | 3.14 | 25.6 | 56.7 | 114 | 1363 |
Sub-cohort | 547 | NA | NA | 0.05 | 31.7 | 66.1 | 156 | 1979 |
Note: DEP, diethylphosphate; DETP, diethylthiophosphate; DEDTP, diethyldithiophosphate; DMP, dimethyphosphate; DMTP, dimethylthiophosphate; DMDTP, dimethyldithiophosphate. * Values for concentrations below the LOQ were imputed. Values standardized to the geometric mean of specific gravity.